\
&
Contact us
\
&
Contact us
Published on | 4 months ago
Programmes Enhancing EU R&IThe European Citizen Science Association (ECSA) and the European Citizen Science (ECS) project have published a position paper in March 2025 on “Citizen science for the future of Europe - Advocating for deeper integration and dedicated support for citizen science in the 10th Framework Programme for Research and Innovation”.
This position paper sets out the added value of citizen science with reference to an extensive list of examples of citizen science investment in Horizon 2020 and Horizon Europe, and outlines 10 opportunities for FP10 to unlock the potential of citizen science through strategic support. The paper concludes with 5 key recommendations for sustained investment in citizen science, and 10 further support areas.
The full position paper, an executive summary (PDF) and the possibility to add an endorsement as individual and/or organization are available on the dedicated website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
